Movano (MOVE) Competitors

$0.47
-0.02 (-4.09%)
(As of 04/22/2024 ET)

MOVE vs. ECOR, POCI, QTI, NRXS, BSGM, HYPR, EYEN, SLGL, ACXP, and ALRN

Should you be buying Movano stock or one of its competitors? The main competitors of Movano include electroCore (ECOR), Precision Optics (POCI), QT Imaging (QTI), NeurAxis (NRXS), BioSig Technologies (BSGM), Hyperfine (HYPR), Eyenovia (EYEN), Sol-Gel Technologies (SLGL), Acurx Pharmaceuticals (ACXP), and Aileron Therapeutics (ALRN). These companies are all part of the "medical" sector.

Movano vs.

electroCore (NASDAQ:ECOR) and Movano (NASDAQ:MOVE) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, community ranking, risk and earnings.

electroCore has a beta of 0.91, suggesting that its share price is 9% less volatile than the S&P 500. Comparatively, Movano has a beta of 0.3, suggesting that its share price is 70% less volatile than the S&P 500.

In the previous week, Movano had 9 more articles in the media than electroCore. MarketBeat recorded 11 mentions for Movano and 2 mentions for electroCore. electroCore's average media sentiment score of 0.16 beat Movano's score of 0.00 indicating that Movano is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
electroCore
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Movano
2 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Neutral

26.7% of electroCore shares are held by institutional investors. Comparatively, 16.6% of Movano shares are held by institutional investors. 13.1% of electroCore shares are held by company insiders. Comparatively, 8.6% of Movano shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

electroCore has higher revenue and earnings than Movano. electroCore is trading at a lower price-to-earnings ratio than Movano, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
electroCore$16.03M2.10-$18.83M-$3.56-1.58
MovanoN/AN/A-$29.28M-$0.65-0.73

Movano has a net margin of 0.00% compared to Movano's net margin of -117.49%. Movano's return on equity of -201.47% beat electroCore's return on equity.

Company Net Margins Return on Equity Return on Assets
electroCore-117.49% -201.47% -109.61%
Movano N/A -361.91%-215.55%

electroCore presently has a consensus target price of $10.00, indicating a potential upside of 77.94%. Given Movano's higher possible upside, equities analysts clearly believe electroCore is more favorable than Movano.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
electroCore
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Movano
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Movano received 19 more outperform votes than electroCore when rated by MarketBeat users. Likewise, 70.66% of users gave Movano an outperform vote while only 62.12% of users gave electroCore an outperform vote.

CompanyUnderperformOutperform
electroCoreOutperform Votes
164
62.12%
Underperform Votes
100
37.88%
MovanoOutperform Votes
183
70.66%
Underperform Votes
76
29.34%

Summary

electroCore beats Movano on 9 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MOVE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MOVE vs. The Competition

MetricMovanoElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$26.25M$2.94B$4.64B$7.31B
Dividend YieldN/A1.82%5.46%3.98%
P/E Ratio-0.7310.72181.0616.24
Price / SalesN/A67.952,596.1880.96
Price / CashN/A50.3031.1927.20
Price / Book7.953.674.594.45
Net Income-$29.28M$85.75M$99.84M$212.71M
7 Day Performance-4.29%5.42%108.82%-0.25%
1 Month Performance16.89%11.21%106.69%-1.31%
1 Year Performance-56.65%-1.98%132.80%5.49%

Movano Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ECOR
electroCore
1.8658 of 5 stars
$5.51
-2.8%
$10.00
+81.5%
-17.5%$33.06M$16.03M-1.5568Gap Down
POCI
Precision Optics
0 of 5 stars
$5.49
+0.5%
N/A-14.0%$33.32M$21.05M-18.3084Positive News
QTI
QT Imaging
0 of 5 stars
$0.85
-21.3%
N/AN/A$18.22MN/A0.00N/AGap Up
NRXS
NeurAxis
0 of 5 stars
$3.13
-1.3%
N/AN/A$16.54M$2.68M0.0017News Coverage
Gap Down
BSGM
BioSig Technologies
0 of 5 stars
$1.51
+37.3%
N/A-89.2%$13.56M$290,000.00-0.3147Gap Down
High Trading Volume
HYPR
Hyperfine
0.9619 of 5 stars
$0.99
-1.0%
$2.12
+113.8%
-43.2%$71.23M$11.03M-1.60131Gap Up
EYEN
Eyenovia
0.6545 of 5 stars
$0.55
flat
$10.00
+1,707.0%
-88.4%$26.23MN/A-0.8357Gap Down
SLGL
Sol-Gel Technologies
3.4913 of 5 stars
$0.94
+9.3%
$8.00
+746.9%
-75.8%$26.32M$1.55M-0.9436Positive News
High Trading Volume
ACXP
Acurx Pharmaceuticals
1.2436 of 5 stars
$1.66
+1.2%
$12.00
+622.9%
-33.4%$26.16MN/A-1.444Gap Up
ALRN
Aileron Therapeutics
2.0453 of 5 stars
$5.35
-9.8%
$9.00
+68.2%
+216.0%$26.16MN/A0.006Gap Down
High Trading Volume

Related Companies and Tools

This page (NASDAQ:MOVE) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners